Christian Angermayer: Investing in the Therapeutic Potential for Psychedelics

Christian Angermayer: Investing in the Therapeutic Potential for Psychedelics

0 Anmeldelser
0
Afsnit
625 of 1994
Længde
1T 7M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

The Interview: Christian Angermayer, founder of Apeiron Investments, Atai Life Sciences, and COMPASS Pathways, made headlines for attributing his decision to invest in Bitcoin to a trip on mushrooms, but his journey as an investor and advocate for psychedelics goes much deeper than the clickbait. In this interview with Mike Green, Angermayer discusses how he went from a successful investor living the straight edge life to founding and eventually IPOing two startups, which are at the cutting edge of research into how mushrooms and other psychedelics could revolutionize the way we think about treating mental health issues. Together, they discuss the parallels between the modern human experience and other times of great change, how this is manifesting itself in societal and individual angst, and why this might make today the perfect time for broader acceptance of these treatments. They also touch on Green's own personal experience with mushrooms and Angermayer's optimistic approach to investing in technologies driving human progress. Recorded on May 8, 2021. Learn more about your ad choices. Visit podcastchoices.com/adchoices


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
Cover for Christian Angermayer: Investing in the Therapeutic Potential for Psychedelics

Other podcasts you might like ...